Last reviewed · How we verify

NCT03913299: FRAIL-HEART

Frailty Assessment by Edmonton Frail Scale to Predict Outcome in Patients Undergoing Cardiovascular Surgery

Active, enrolled Last updated 15 April 2025
What this trial tests

trial in Frail Elderly Syndrome in 2,080 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
23 April 2019
Primary endpoint
1 April 2025
30 September 2026

Quick facts

Lead sponsorCliniques universitaires Saint-Luc- Université Catholique de Louvain
StatusActive, enrolled
Study typeOBSERVATIONAL
Enrollment2,080
Start date23 April 2019
Primary completion1 April 2025
Estimated completion30 September 2026
Sites3 locations across Belgium

Conditions studied

Sponsor

Cliniques universitaires Saint-Luc- Université Catholique de Louvain — full company profile →

Who can join

18 and older, any sex, with Frail Elderly Syndrome or Frailty. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to assess frailty of patients admited for cardio-vascular surgery in Cliniques Universitaires Saint Luc in Brussels. And analyse the correlation between frailty, functionnal decline and postoperative mortality.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Frail Elderly Syndrome

Currently open trials in the same condition.

Other Cliniques universitaires Saint-Luc- Université Catholique de Louvain trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03913299.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing